The ethics of access to patented biotech research tools from universities and other research institutions
Journal article, Peer reviewed
MetadataShow full item record
Original versionNature Biotechnology. 2018, 36 (6), 495-499. 10.1038/nbt.4165
As universities and public research organizations increasingly partner with industry to fulfill their 'third mission' of innovation activities for economic and societal benefit, they have ethical obligations to ensure access to patented research tools, especially CRISPR–Cas9 technology.